BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 29342159)

  • 1. Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer.
    Makondi PT; Lee CH; Huang CY; Chu CM; Chang YJ; Wei PL
    PLoS One; 2018; 13(1):e0189582. PubMed ID: 29342159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
    Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
    Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.
    Peng C; Ma W; Xia W; Zheng W
    Mol Med Rep; 2017 Mar; 15(3):1087-1094. PubMed ID: 28075450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer.
    Makondi PT; Chu CM; Wei PL; Chang YJ
    PLoS One; 2017; 12(7):e0180616. PubMed ID: 28749961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of key genes in colorectal cancer using random walk with restart.
    Cui X; Shen K; Xie Z; Liu T; Zhang H
    Mol Med Rep; 2017 Feb; 15(2):867-872. PubMed ID: 28000901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico analysis to identify miR-1271-5p/PLCB4 (phospholipase C Beta 4) axis mediated oxaliplatin resistance in metastatic colorectal cancer.
    Lee CC; Lee AW; Wei PL; Liu YS; Chang YJ; Huang CY
    Sci Rep; 2023 Mar; 13(1):4366. PubMed ID: 36927770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
    Yu Y; Tian X
    Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated regulatory mechanisms of miRNAs and targeted genes involved in colorectal cancer.
    Wang J; Yu H; Ye L; Jin L; Yu M; Lv Y
    Int J Clin Exp Pathol; 2015; 8(1):517-29. PubMed ID: 25755742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
    Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C
    Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling analysis of the role of miR-22 in clear cell ovarian cancer.
    Zhen YB; Guo XL; Xu B; Zhao HW; Xu CJ
    Neoplasma; 2016; 63(6):856-864. PubMed ID: 27565323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.
    Chen J; Wang Z; Shen X; Cui X; Guo Y
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics analysis of fibroblasts exposed to TGF‑β at the early proliferation phase of wound repair.
    Mi B; Liu G; Zhou W; Lv H; Zha K; Liu Y; Wu Q; Liu J
    Mol Med Rep; 2017 Dec; 16(6):8146-8154. PubMed ID: 28983581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the interaction network of hub genes for melanoma treated with vemurafenib based on microarray data.
    Quan L; Wang Y; Liang J; Shi J; Zhang Y; Tao K
    Tumori; 2015; 101(4):368-74. PubMed ID: 25983087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of genes involved in the four stages of colorectal cancer: Gene expression profiling.
    Shi G; Wang Y; Zhang C; Zhao Z; Sun X; Zhang S; Fan J; Zhou C; Zhang J; Zhang H; Liu J
    Mol Cell Probes; 2018 Feb; 37():39-47. PubMed ID: 29179987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of hub genes, key miRNAs and potential molecular mechanisms of colorectal cancer.
    Wu S; Wu F; Jiang Z
    Oncol Rep; 2017 Oct; 38(4):2043-2050. PubMed ID: 28902367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of key genes and pathways in benign prostatic hyperplasia.
    Ke ZB; Cai H; Wu YP; Lin YZ; Li XD; Huang JB; Sun XL; Zheng QS; Xue XY; Wei Y; Xu N
    J Cell Physiol; 2019 Nov; 234(11):19942-19950. PubMed ID: 31187492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Key Genes and miRNAs in Osteosarcoma Patients with Chemoresistance by Bioinformatics Analysis.
    Xie B; Li Y; Zhao R; Xu Y; Wu Y; Wang J; Xia D; Han W; Chen D
    Biomed Res Int; 2018; 2018():4761064. PubMed ID: 29850522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis.
    Xu Z; Zhou Y; Cao Y; Dinh TL; Wan J; Zhao M
    Med Oncol; 2016 Nov; 33(11):130. PubMed ID: 27757782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening candidate genes associated with bladder cancer using DNA microarray.
    Xu A; Wang C; Sun S
    Mol Med Rep; 2014 Dec; 10(6):3087-91. PubMed ID: 25323786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.